ArticleJournal of oncology2022

Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World Study.

Jingjing Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.